October 6, 2009 – The Harvard Clinical Research Institute (HCRI) said last week the first patients are enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual anti-platelet therapy (DAPT, the combination of aspirin and a thienopyridine/anti-platelet medication to reduce the risk of blood clots) following drug-eluting stent i

October 6, 2009 - Boston Scientific Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures.

October 6, 2009 – Direct Flow Medical Inc. released its One-year data from the initial clinical trial for its transcatheter prosthetic aortic valve during the recent Transcatheter Cardiovascular Therapeutics (TCT) 2009 meeting .

October 6, 2009 – New research shows magnetic interference from portable headphones has a clinically significant impact on the function of life-saving devices, according to a new study published in the October edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society.

October 6, 2009 – ProSolv CardioVascular, a Fujifilm company, recently said the Veterans in Partnership Healthcare Network (VISN 11) has extended its relationship with the company by contracting to add the Synapse ProSolv Cardiovascular solution in four additional hospitals.

October 6, 2009 – Boston Scientific Corp. released data during TCT 2009 from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberté Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.

The AMICAS One Suite of products provides a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully integrated, hospital information system-independent PACS that features advanced enterprise workflow support and scalable design. The suite includes the following tools:

October 5, 2009 – The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) has awarded a grant to the American College of Cardiology (ACC) in partnership with the Society of Thoracic Surgeons (STS) to study the comparative effectiveness of the two forms of coronary revascularization – percutaneous coronary intervention (PCI) and coronary artery bypass graft (CAB

October 5, 2009 – In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

October 5, 2009 – A reduction in stroke was observed in patients with atrial fibrillation (AF) who received dronedarone (MULTAQ), according to a recent study published online in Circulation – “Analysis of Stroke in A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Caus

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now